174 related articles for article (PubMed ID: 18815890)
1. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.
El-Hage N; Bruce-Keller AJ; Knapp PE; Hauser KF
J Neuroimmune Pharmacol; 2008 Dec; 3(4):275-85. PubMed ID: 18815890
[TBL] [Abstract][Full Text] [Related]
2. Morphine exposure exacerbates HIV-1 Tat driven changes to neuroinflammatory factors in cultured astrocytes.
Chen K; Phan T; Lin A; Sardo L; Mele AR; Nonnemacher MR; Klase Z
PLoS One; 2020; 15(3):e0230563. PubMed ID: 32210470
[TBL] [Abstract][Full Text] [Related]
3. beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration.
Hahn YK; Vo P; Fitting S; Block ML; Hauser KF; Knapp PE
J Neurochem; 2010 Jul; 114(1):97-109. PubMed ID: 20403075
[TBL] [Abstract][Full Text] [Related]
4. Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner.
Leibrand CR; Paris JJ; Jones AM; Ohene-Nyako M; Rademeyer KM; Nass SR; Kim WK; Knapp PE; Hauser KF; McRae M
Neurosci Lett; 2022 Sep; 788():136852. PubMed ID: 36028004
[TBL] [Abstract][Full Text] [Related]
5. Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids.
Hermes DJ; Jacobs IR; Key MC; League AF; Yadav-Samudrala BJ; Xu C; McLane VD; Nass SR; Jiang W; Meeker RB; Ignatowska-Jankowska BM; Lichtman AH; Li Z; Wu Z; Yuan H; Knapp PE; Hauser KF; Fitting S
J Neuroinflammation; 2020 Nov; 17(1):345. PubMed ID: 33208151
[TBL] [Abstract][Full Text] [Related]
6. Opiate drug use and the pathophysiology of neuroAIDS.
Hauser KF; Fitting S; Dever SM; Podhaizer EM; Knapp PE
Curr HIV Res; 2012 Jul; 10(5):435-52. PubMed ID: 22591368
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology.
Hauser KF; Hahn YK; Adjan VV; Zou S; Buch SK; Nath A; Bruce-Keller AJ; Knapp PE
Glia; 2009 Jan; 57(2):194-206. PubMed ID: 18756534
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat promotes astrocytic release of CCL2 through MMP/PAR-1 signaling.
Bozzelli PL; Yin T; Avdoshina V; Mocchetti I; Conant KE; Maguire-Zeiss KA
Glia; 2019 Sep; 67(9):1719-1729. PubMed ID: 31124192
[TBL] [Abstract][Full Text] [Related]
9. Depressive-like Behavior Is Accompanied by Prefrontal Cortical Innate Immune Fatigue and Dendritic Spine Losses after HIV-1 Tat and Morphine Exposure.
Nass SR; Hahn YK; Ohene-Nyako M; McLane VD; Damaj MI; Thacker LR; Knapp PE; Hauser KF
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992299
[TBL] [Abstract][Full Text] [Related]
10. Different Roles of Beclin1 in the Interaction Between Glia and Neurons after Exposure to Morphine and the HIV- Trans-Activator of Transcription (Tat) Protein.
Lapierre J; Karuppan MKM; Perry M; Rodriguez M; El-Hage N
J Neuroimmune Pharmacol; 2022 Dec; 17(3-4):470-486. PubMed ID: 34741242
[TBL] [Abstract][Full Text] [Related]
11. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes.
Kutsch O; Oh J; Nath A; Benveniste EN
J Virol; 2000 Oct; 74(19):9214-21. PubMed ID: 10982368
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat and morphine interactions dynamically shift striatal monoamine levels and exploratory behaviors over time.
Lark ARS; Nass SR; Hahn YK; Gao B; Milne GL; Knapp PE; Hauser KF
J Neurochem; 2024 Mar; 168(3):185-204. PubMed ID: 38308495
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure.
Marks WD; Paris JJ; Barbour AJ; Moon J; Carpenter VJ; McLane VD; Lark ARS; Nass SR; Zhang J; Yarotskyy V; McQuiston AR; Knapp PE; Hauser KF
eNeuro; 2021; 8(3):. PubMed ID: 33782102
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice.
Rademeyer KM; R Nass S; Jones AM; Ohene-Nyako M; Hauser KF; McRae M
J Neurovirol; 2024 Feb; 30(1):1-21. PubMed ID: 38280928
[TBL] [Abstract][Full Text] [Related]
15. Morphine enhances HIV infection of neonatal macrophages.
Li Y; Merrill JD; Mooney K; Song L; Wang X; Guo CJ; Savani RC; Metzger DS; Douglas SD; Ho WZ
Pediatr Res; 2003 Aug; 54(2):282-8. PubMed ID: 12736382
[TBL] [Abstract][Full Text] [Related]
16. Myelin regulatory factor is a target of individual and interactive effects of HIV-1 Tat and morphine in the striatum and pre-frontal cortex.
Flounlacker KM; Hahn YK; Xu R; Simons CA; Tian T; Hauser KF; Knapp PE
J Neurovirol; 2023 Feb; 29(1):15-26. PubMed ID: 36853588
[TBL] [Abstract][Full Text] [Related]
17. Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal Ganglia.
Ohene-Nyako M; Nass SR; Richard HT; Lukande R; Nicol MR; McRae M; Knapp PE; Hauser KF
ASN Neuro; 2023; 15():17590914231158218. PubMed ID: 36890725
[TBL] [Abstract][Full Text] [Related]
18. Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy.
Wodarski R; Bagdas D; Paris JJ; Pheby T; Toma W; Xu R; Damaj MI; Knapp PE; Rice ASC; Hauser KF
Pain Rep; 2018 May; 3(3):e654. PubMed ID: 29922746
[TBL] [Abstract][Full Text] [Related]
19. Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.
Hauser KF; Knapp PE
Int Rev Neurobiol; 2014; 118():231-313. PubMed ID: 25175867
[TBL] [Abstract][Full Text] [Related]
20. Chronic HIV-1 Tat exposure alters anterior cingulate cortico-basal ganglia-thalamocortical synaptic circuitry, associated behavioral control, and immune regulation in male mice.
Nass SR; Hahn YK; McLane VD; Varshneya NB; Damaj MI; Knapp PE; Hauser KF
Brain Behav Immun Health; 2020 May; 5():. PubMed ID: 33083793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
